过去一年中添加的文章,按日期排序

Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular diseases: Advances in genome editing and CAR T cell therapy

S Soroudi, MR Jaafari, L Arabi - Journal of Controlled Release, 2024 - Elsevier
5 天前 - … used in COVID-19 vaccines, have a great potential to deliver mRNA therapeutics
for … , SMRT, and barcoded LNPs) hold great prospects to accelerate the development and …

DESIGNING URBAN GREEN SPACE AS THERAPEUTIC LANDSCAPE IN CHINA

Y Wang - esploro.libs.uga.edu
15 天前 - COVID-19 pandemic in the 21st century, people are searching for new strategies to
address public health crises, and the use of therapeuticprospects for horticultural therapy, …

[HTML][HTML] Rational Design of Lipid-Based Vectors for Advanced Therapeutic Vaccines

Y Ma, Y Chen, Z Li, Y Zhao - Vaccines, 2024 - mdpi.com
20 天前 - … /Pfizer and Moderna against COVID-19, have gained approval for … current challenges
and future prospects in translating lipid… against coronavirus disease 2019 (COVID-19) [9]. …

mRNA-based Vaccines–Global Approach, Challenges, and Could Be a Promising Wayout for Future Pandemics

S Makhijani, GM Elossaily, S Rojekar… - Pharmaceutical …, 2024 - Taylor & Francis
21 天前 - … of therapeutic implementation. Finally, recent mRNA-based vaccines in clinical trials,
adjuvant benefits, and prospects … after the coronavirus disease-2019 (COVID-19) outbreak. …

[HTML][HTML] Identification of Marker Genes in Infectious Diseases from ScRNA-seq Data Using Interpretable Machine Learning

G Sganzerla Martinez, A Garduno… - International Journal of …, 2024 - mdpi.com
22 天前 - prospects as diagnostic markers and providing potential targets for therapeutic
by cells from COVID-19 patients would be distinct from non-COVID-19 patients (Figure 5D). We …

Isoflavonoids As Bioactive Molecules against SARS-CoV-2

S Jayashree, K Sonia, G Mayakkannan… - Anti-SARS-CoV-2 … - taylorfrancis.com
25 天前 - … Additional research on pharmacological studies, with a particular emphasis on
bioavailability, could lead to the discovery of supplementary therapy for COVID19 or other new …

Molecular Insights into Anti-SARS-CoV-2 Activity of Catechins against Protein Targets for COVID-19 Management

N Rajak, VK Singh, N Garg - Anti-SARS-CoV-2 Activity of …, 2024 - taylorfrancis.com
25 天前 - … candidates in COVID19 patients. … COVID19, as well as provide preclinical
and clinical evidence that catechins could be utilized as antiviral agents in managing COVID19

Advances in Antiviral Drug Development: Current Trends and Future Perspectives

D Dodtale, B Tiwari, S Gujar - International Journal of Research …, 2024 - journal.ijresm.com
30 天前 - … issues, like as the COVID19 pandemic, the … prospects including the use of
CRISPR-Cas system, monoclonal antibodies, and nanoparticles. In addition to improving therapeutic

[HTML][HTML] Deep learning facilitates efficient optimization of antisense oligonucleotide drugs

S Lin, L Hong, DQ Wei, Y Xiong - Molecular Therapy-Nucleic Acids, 2024 - cell.com
35 天前 - Nucleic acid therapeutics exert their therapeutic effects by targeting specific genes …
2 mRNA vaccines have demonstrated high efficacy and reliability during the COVID-19

[HTML][HTML] Survivin: A key apoptosis inhibitor in COVID-19 infection and its implication for treatment protocol

FQB Alenzi - Saudi Journal of Biological Sciences, 2024 - Elsevier
39 天前 - COVID-19 exhibited higher survivin rates, suggesting a protective role for survivin in
migitating lung damage. These findings suggest the prospect … severe COVID-19 ouctomes. …